Top Markets
#1 MowCat MowCat +48.24%
#2 Velvet Velvet +24.18%
#3 Bitway Bitway +22.81%
#4 aPriori aPriori +19.56%
#5 OVERTAKE OVERTAKE +18.77%
#6 Biconomy Biconomy +15.79%
#7 Derive Derive +14.39%
#8 Zerebro Zerebro +12.76%
#9 DODO DODO +11.91%
#10 Perle Perle +11.36%
Coin of the day
MowCat MowCat
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
WPD Pharmaceuticals Inc. WPD Pharmaceuticals Inc.

WPD Pharmaceuticals Inc.

WBIO
Hisse Senetlerindeki Sıralama #34463
WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver,... WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver, Canada, specializes in the research and advancement of therapeutic products for oncology and infectious diseases. The company's diverse drug development pipeline features multiple promising candidates: WPD101 and WPD103 are both in pre-clinical stages, targeting brain cancers, including glioblastoma and glioblastoma multiforme respectively. Also in pre-clinical development is WPD102, aimed at Uveal Melanoma. In more advanced clinical stages, Berubicin is undergoing Phase 1 trials for glioblastoma, while WP1066, also in Phase 1 clinical trials, is being investigated for central nervous system tumors, pancreatic cancer, and ocular tumors. Additionally, the pipeline includes WP1732 for pancreatic cancer and WP1220 for cutaneous T-cell lymphoma. Annamycin is currently in Phase I/II clinical trials for acute myeloid leukemia (AML) and is also being explored for lung metastasis.
Hisse Fiyatı
$0.04895618
Son senkronizasyon: 2025-03-18
Piyasa Değeri
$5.55M
Değişim (1 gün)
-0.04%
Değişim (1 yıl)
0.00%
Ülke
CA
Ticaret WPD Pharmaceuticals Inc. (WBIO)

Kategori

Healthcare
WPD Pharmaceuticals Inc. (WBIO) için kazanç
2026 itibarıyla kazanç TTM: 0
WPD Pharmaceuticals Inc. şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
WPD Pharmaceuticals Inc. için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE